Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VELAGLUCERASE ALFA for Fabry's disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where VELAGLUCERASE ALFA was used for Fabry's disease.

Most Reported Side Effects for VELAGLUCERASE ALFA

Side Effect Reports % Deaths Hosp.
Inappropriate schedule of product administration 197 11.3% 10 93
Product dose omission issue 188 10.8% 15 83
Covid-19 163 9.3% 12 71
Fatigue 136 7.8% 6 57
Death 108 6.2% 108 35
Fall 104 6.0% 10 68
Pyrexia 101 5.8% 13 62
Malaise 98 5.6% 6 55
Weight increased 89 5.1% 7 50
Headache 88 5.0% 1 37
Arthralgia 84 4.8% 3 43
Infusion related reaction 78 4.5% 2 20
Weight decreased 78 4.5% 7 51
Pneumonia 77 4.4% 27 55
Nausea 75 4.3% 5 39

Other Indications for VELAGLUCERASE ALFA

Gaucher's disease (1,379) Product used for unknown indication (196) Gaucher's disease type i (132) Lipidosis (31) Gaucher's disease type ii (19) Gaucher's disease type iii (13)

Other Drugs Used for Fabry's disease

AGALSIDASE BETA (4,670) MIGALASTAT (407) PEGUNIGALSIDASE ALFA-IWXJ (161) FABRAZYME (154) AGALSIDASE ALFA (71) IMIGLUCERASE (40) IDURSULFASE (14) HYDROXYCHLOROQUINE (9) MIGLUSTAT (9) ACETAMINOPHEN (8)

Related Pages

VELAGLUCERASE ALFA Full Profile All Fabry's disease Drugs VELAGLUCERASE ALFA Demographics VELAGLUCERASE ALFA Timeline